Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ascom Holding AGXSWX:ASCN -0.36%71 Future 3-5Y EPS without NRI Growth Rate is 5.39 as of Sep. 10, 2026. GuruFocus rates XSWX:ASCN with a GF Score™ of 71/100 and a GF Value™ of CHF5.66 (Fairly Valued). Among 200 Healthcare Providers & Services companies, Ascom Holding AG ranks worse than 90.5% on this metric.
Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.
As of today, Ascom Holding AG's Future 3-5Y EPS without NRI Growth Rate is 5.39.
Ascom Holding AG (XSWX:ASCN) Future 3-5Y EPS without NRI Growth Rate Explanation
Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.
Ascom Holding AG Future 3-5Y EPS without NRI Growth Rate Related Terms
XSWX:ASCN vs VEEV, BTSG, TEM: Future 3-5Y EPS without NRI Growth Rate Comparison
For the Health Information Services subindustry, Ascom Holding AG's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ascom Holding AG Future 3-5Y EPS without NRI Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ascom Holding AG's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Ascom Holding AG's Future 3-5Y EPS without NRI Growth Rate falls into.
What does a Future 3-5Y EPS without NRI Growth Rate of 5.39 mean?
Ascom Holding AG (XSWX:ASCN) has a Future 3-5Y EPS without NRI Growth Rate of 5.39 as of Sep. 10, 2026. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for Ascom Holding AG and its competitors. According to the industry distribution chart, Ascom Holding AG ranks #181 out of 200 companies in the Healthcare Providers & Services industry, placing it in the top 90.5%.
Is Ascom Holding AG's Future 3-5Y EPS without NRI Growth Rate too high?
Ascom Holding AG's current Future 3-5Y EPS without NRI Growth Rate is 5.39. The Healthcare Providers & Services industry median Future 3-5Y EPS without NRI Growth Rate is 17.27. Ascom Holding AG's value of 5.39 is 68.8% below this industry median. Based on the distribution chart, Ascom Holding AG ranks #181 out of 200 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Ascom Holding AG has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ascom Holding AG's Future 3-5Y EPS without NRI Growth Rate compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Ascom Holding AG ranks #181 out of 200 companies for Future 3-5Y EPS without NRI Growth Rate. This places Ascom Holding AG in the lower half of its industry. The industry median Future 3-5Y EPS without NRI Growth Rate is 17.27. Ascom Holding AG's value of 5.39 is 68.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Future 3-5Y EPS without NRI Growth Rate for a Healthcare Providers & Services company?
The median Future 3-5Y EPS without NRI Growth Rate among Healthcare Providers & Services companies is 17.27, based on 200 companies in the industry. Companies in the top quartile (top 25%) have a Future 3-5Y EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, Future 3-5Y EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ascom Holding AG's current Future 3-5Y EPS without NRI Growth Rate of 5.39 is 68.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Future 3-5Y EPS without NRI Growth Rate mean?
A high Future 3-5Y EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for Ascom Holding AG and its competitors. For the Healthcare Providers & Services industry, the median Future 3-5Y EPS without NRI Growth Rate is 17.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ascom Holding AG's current Future 3-5Y EPS without NRI Growth Rate is 5.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascom Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Ascom Holding AG (XSWX:ASCN) is currently considered Fairly Valued. The stock's GF Value™ is CHF5.66, compared to a current price of CHF5.55 — trading 1.9% below its estimated fair value. The current Future 3-5Y EPS without NRI Growth Rate is 5.39 and 68.8% below the Healthcare Providers & Services industry median of 17.27. Ascom Holding AG's overall GF Score™ is 71/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Future 3-5Y EPS without NRI Growth Rate calculated?
Future 3-5Y EPS without NRI Growth Rate is calculated from a company's financial statements. For Ascom Holding AG (XSWX:ASCN), the current Future 3-5Y EPS without NRI Growth Rate is 5.39 as of Sep. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ascom Holding AG (XSWX:ASCN) Overvalued in 2026?
Based on GuruFocus' analysis, Ascom Holding AG stock appears to be undervalued.
The current stock price of CHF5.55 is trading 1.9% below its estimated GF Value™ of CHF5.66.
GuruFocus considers Ascom Holding AG to be Fairly Valued.
Key valuation signals for XSWX:ASCN:
Future 3-5Y EPS without NRI Growth Rate: 5.39
GF Value™: CHF5.66 vs. price of CHF5.55 (1.9% below fair value)
Industry Position: 68.8% below the Healthcare Providers & Services median (#181 of 200)
No single metric tells the full story. See the XSWX:ASCN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ascom Holding AG is a solutions provider of ICT and mobile workflow solutions in the healthcare and enterprise sectors. The company consists of a business unit, the purpose of which is to use its product and solutions portfolio and software architecture capabilities to devise integration and mobilization solutions that provide digitalized, complete, and efficient workflows for healthcare as well as for industry, security, and retail sectors. The company has three segments OEM, Enterprise, and Healthcare. It derives a majority of revenue from the healthcare segment.
71GF Score
Get the complete analysis for XSWX:ASCN
Future 3-5Y EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:ASCN has been successfully added to your 
